Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamArthritis Research Canada's scientists and trainees regularly present new findings that advance arthritis prevention, treatment, and care.
Browse Conference AbstractsPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Your experience with arthritis matters. Sharing it helps others feel less alone and brings the human reality of arthritis into everything we do.
Reason For Research
Doctors and rheumatoid arthritis patients rely on clear, current information when choosing the best treatments. New research is published constantly, and each clinical trial may produce many separate scientific papers. This makes it time-consuming and difficult to sort through and stay on top of all the information. This project, STREAM-AI (Systematic Trial Record Extraction and Matching using Artificial Intelligence), will aim to make this process faster and more accurate using artificial intelligence.
Execution of Research
This project will create a new artificial intelligence tool that can:
By combining medical and artificial intelligence expertise, this project will help keep rheumatoid arthritis treatment recommendations up to date more efficiently, ensuring that patients and healthcare providers have access to the best available evidence.
Involvement
The work is embedded within several large international consortiums, including Cochrane, and rheumatology guideline groups.